Meeting
2022 ASCO Annual Meeting
Gut microbiota composition and outcomes following neoadjuvant therapy in patients with localized pancreatic cancer: A prospective biomarker study.
Authors
Pranav Murthy
Department of Surgery, University of Pittsburgh, Pittsburgh, PA
Pranav Murthy , Kelvin Li , Renee R. Anderko , Aatur D. Singhi , Annissa DeSilva , Asmita Chopra , Abdulraham Y. Hammad , Alessandro Paniccia , Alison Morris , Kenneth K. Lee , Robbie B. Mailliard , Michael T. Lotze , Barbara Methe , Amer H. Zureikat
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4143)
DOI
10.1200/JCO.2022.40.16_suppl.4143
Abstract #
4143
Poster Bd #
128
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of race and CA 19-9 nonproduction with limited pathologic response to neoadjuvant chemotherapy in patients with localized pancreatic cancer.
First Author: Mary P. Martos
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effect of neoadjuvant therapy pathway (NATP) for pancreatic cancer on overall patient outcomes.
First Author: Dylan Cooper
Poster
2022 ASCO Quality Care Symposium
Association of clinic type with receipt of neoadjuvant therapy among patients with localized pancreatic cancer: Value of multidisciplinary clinic.
First Author: Priya Pathak
Poster
2018 Gastrointestinal Cancers Symposium
Markov decision analysis of neoadjuvant treatment pathway versus surgery first pathway for resectable pancreatic cancer.
First Author: Alison Bradley